{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:46:13Z","timestamp":1761918373558},"reference-count":73,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2000,8]]},"DOI":"10.1053\/bega.2000.0107","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T09:54:50Z","timestamp":1032429290000},"page":"615-628","source":"Crossref","is-referenced-by-count":14,"title":["Treatment of primary biliary cirrhosis"],"prefix":"10.1053","volume":"14","author":[{"given":"Raoul","family":"Poupon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9e Eug\u00e9nie","family":"Poupon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/bega.2000.0107_RF1","series-title":"Hepatology. A Textbook of Liver Disease","first-page":"1329","article-title":"Primary biliary cirrhosis","author":"Poupon","year":"1996"},{"key":"10.1053\/bega.2000.0107_RF2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/gut.20.2.137","article-title":"Serum bilirubin: a prognostic factor in primary biliary cirrhosis","volume":"20","author":"Shapiro","year":"1979","journal-title":"Gut"},{"key":"10.1053\/bega.2000.0107_RF3","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0016-5085(80)90571-5","article-title":"Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients","volume":"78","author":"Christensen","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0107_RF4","series-title":"Progress in Liver Diseases","first-page":"336","article-title":"Non-suppurative destructive chronic cholangitis and chronic hepatitis","author":"Popper","year":"1970"},{"key":"10.1053\/bega.2000.0107_RF5","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0016-5085(76)80250-8","article-title":"A prospective controlled trial of azathioprine in primary biliary cirrhosis","volume":"70","author":"Heathcote","year":"1976","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0107_RF6","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/0016-5085(85)90213-6","article-title":"Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial","volume":"89","author":"Christensen","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0107_RF7","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(81)92456-9","article-title":"D-penicillamine treatment improves survival in primary biliary cirrhosis","volume":"i","author":"Epstein","year":"1981","journal-title":"Lancet"},{"key":"10.1053\/bega.2000.0107_RF8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJM198202113060602","article-title":"A prospective trial of D-penicillamine in primary biliary cirrhosis","volume":"306","author":"Matloff","year":"1982","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2000.0107_RF9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/gut.26.2.109","article-title":"D-Penicillamine for primary biliary cirrhosis","volume":"26","author":"James","year":"1985","journal-title":"Gut"},{"key":"10.1053\/bega.2000.0107_RF10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1600-0676.1983.tb00887.x","article-title":"Low therapeutic value of D-penicillamine in a short-term prospective trial in primary biliary cirrhosis","volume":"3","author":"Taal","year":"1983","journal-title":"Liver"},{"key":"10.1053\/bega.2000.0107_RF11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/gut.26.2.114","article-title":"Double blind controlled trial of D-penicillamine in patients with primary biliary cirrhosis","volume":"26","author":"Neuberger","year":"1985","journal-title":"Gut"},{"key":"10.1053\/bega.2000.0107_RF12","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/hep.1840050613","article-title":"A prospective clinical trial of D-penicillamine in the treatment of primary biliary cirrhosis","volume":"5","author":"Bodenheimer","year":"1985","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0107_RF13","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJM198504183121602","article-title":"Trial of penicillamine in advanced primary biliary cirrhosis","volume":"312","author":"Dickson","year":"1985","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2000.0107_RF14","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/0168-8278(92)90065-W","article-title":"A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results","volume":"15","author":"Mitchison","year":"1992","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0107_RF15","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJM199005173222003","article-title":"A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis","volume":"322","author":"Wiesner","year":"1990","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2000.0107_RF16","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0016-5085(93)90422-9","article-title":"Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial","volume":"104","author":"Lombard","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0107_RF17","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJM198612043152304","article-title":"A prospective trial of colchicine for primary biliary cirrhosis","volume":"315","author":"Kaplan","year":"1986","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2000.0107_RF18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-8278(87)80053-3","article-title":"A controlled trial of colchicine in primary biliary cirrhosis. Trial design and preliminary report","volume":"5","author":"Warnes","year":"1987","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0107_RF19","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0016-5085(88)90300-9","article-title":"Evaluation of colchicine therapy in primary biliary cirrhosis","volume":"95","author":"Bodenheimer","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0107_RF20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-109-5-429","article-title":"Primary biliary cirrhosis treated with low-dose oral pulse methotrexate","volume":"109","author":"Kaplan","year":"1988","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/bega.2000.0107_RF21","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/gast.1999.0029900400","article-title":"Low-dose of methotrexate is ineffective in primary biliary cirrhosis: long-term results of a placebo-controlled trial","volume":"117","author":"Hendrickse","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0107_RF22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/hep.1840110104","article-title":"Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid","volume":"11","author":"Calmus","year":"1990","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0107_RF23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF03401914","article-title":"Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production","volume":"4","author":"Rodrigues","year":"1998","journal-title":"Molecular Medicine"},{"key":"10.1053\/bega.2000.0107_RF24","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/hep.510280601","article-title":"Ursodeoxycholic acid in cholestasis: potential mechanisms of action and therapeutic applications","volume":"28","author":"Beuers","year":"1998","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0107_RF25","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0016-5085(97)70183-5","article-title":"Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis","volume":"113","author":"Poupon","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0107_RF26","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/hep.510290603","article-title":"Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis","volume":"29","author":"Poupon","year":"1999","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0107_RF27","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/hep.510290301","article-title":"Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis","volume":"29","author":"Angulo","year":"1999","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0107_RF28","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0168-8278(00)80216-0","article-title":"Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial","volume":"32","author":"Par\u00e9s","year":"2000","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0107_RF29","first-page":"474","article-title":"A Markov model for assessment of histological progression in PBC provides evidence that UDCA therapy is effective in early stages","volume":"30","author":"Corpechot","year":"1999","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0107_RF30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/hep.510290140","article-title":"Clinical significance of serum bilirubin levels under ursodeoxycholic acid therapy in patients with primary biliary cirrhosis","volume":"29","author":"Bonnand","year":"1999","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0107_RF31","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.4065\/72.12.1137","article-title":"Ursodeoxycholic acid delays the onset of esophageal varices in primary biliary cirrhosis","volume":"72","author":"Lindor","year":"1997","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1053\/bega.2000.0107_RF32","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1046\/j.1365-2036.1998.00395.x","article-title":"A randomized trial in primary biliary cirrhosis comparing ursodeoxycholic acid in daily doses of either 10mg\/kg or 20mg\/kg","volume":"12","author":"van Hoogstraten","year":"1998","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2000.0107_RF33","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0168-8278(99)80136-6","article-title":"Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial","volume":"30","author":"Angulo","year":"1999","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0107_RF34","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(98)11293-X","article-title":"Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis","volume":"354","author":"Goulis","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/bega.2000.0107_RF35","first-page":"83","article-title":"Ursodeoxycholic acid (UDCA) in primary biliary cirrhosis (PBC)\u2014a Cochrane hepato-biliary systemic review","volume":"30","author":"Gluud","year":"1999","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0107_RF36","first-page":"689","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis: lessons from the past\u2014issues for the future","volume":"32","author":"Poupon","year":"2000","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0107_RF37","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1056\/NEJM199708213370806","article-title":"Discrepancies between meta-analyses and subsequent large randomized, controlled trials","volume":"337","author":"LeLorier","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2000.0107_RF38","series-title":"Bile Acids as Therapeutic Agents. From Basic Science to Clinical Practice","first-page":"301","article-title":"Effects of ursodeoxycholic acid and ursodeoxycholic acid plus colchicine in primary biliary cirrhosis: a double-blind pilot study","author":"Raedsch","year":"1991"},{"key":"10.1053\/bega.2000.0107_RF39","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0168-8278(96)80191-7","article-title":"Effects of additional administration of colchicine in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: a prospective randomized study","volume":"24","author":"Ikeda","year":"1996","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0107_RF40","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/hep.510240520","article-title":"A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis","volume":"24","author":"Poupon","year":"1994","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0107_RF41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0168-8278(05)80004-2","article-title":"Positive responses to methotrexate and ursodeoxycholic acid in patients with primary biliary cirrhosis responding insufficiently to ursodeoxycholic acid alone","volume":"18","author":"Buscher","year":"1993","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0107_RF42","first-page":"1158","article-title":"The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: the results of a pilot study","volume":"22","author":"Lindor","year":"1995","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0107_RF43","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/17843286.1996.11718480","article-title":"Combined treatment with methotrexate and ursodeoxycholic acid in non-cirrhotic primary biliary cirrhosis","volume":"51","author":"van Steenbergen","year":"1996","journal-title":"Acta Clinica Belgica"},{"key":"10.1053\/bega.2000.0107_RF44","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0168-8278(97)80294-2","article-title":"The combination of ursodeoxycholic acid and methotrexate for primary biliary cirrhosis is not better than ursodeoxycholic acid alone","volume":"27","author":"Gonzales-Koch","year":"1997","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0107_RF45","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/gast.1999.0029900395","article-title":"Methotrexate improves biochemical tests in patients with primary biliary cirrhosis who respond incompletely to ursodiol","volume":"117","author":"Bonis","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0107_RF46","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0168-8278(96)80327-8","article-title":"Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis","volume":"25","author":"Leuschner","year":"1996","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0107_RF47","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0168-8278(98)80254-7","article-title":"Triple therapy with ursodeoxycholic acid, prednisone, and aziathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled study","volume":"29","author":"Wolfhagen","year":"1998","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0107_RF48","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0016-5085(99)70351-3","article-title":"Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial","volume":"117","author":"Leuschner","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0107_RF49","first-page":"471","article-title":"Budesonide in the treatment of patients with primary biliary cirrhosis with suboptimal response to ursodeoxycholic acid","volume":"20","author":"Angulo","year":"1999","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0107_RF50","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1055\/s-2007-1007360","article-title":"The pruritus of cholestasis","volume":"13","author":"Bergasa","year":"1993","journal-title":"Seminars in Liver Disease"},{"key":"10.1053\/bega.2000.0107_RF51","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/0002-9343(81)90857-3","article-title":"Pruritus in cholestasis: no direct cause for bile acid retention","volume":"70","author":"Friedman","year":"1981","journal-title":"American Journal of Medicine"},{"key":"10.1053\/bega.2000.0107_RF52","first-page":"117","article-title":"Pruritus of cholestasis is related to effects of bile salts on the liver, not the skin","volume":"82","author":"Ghent","year":"1987","journal-title":"American Journal of Gastrotenterology"},{"key":"10.1053\/bega.2000.0107_RF53","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1136\/bmj.297.6662.1501","article-title":"Opioid peptides and primary biliary cirrhosis","volume":"297","author":"Thornton","year":"1988","journal-title":"British Medical Journal"},{"key":"10.1053\/bega.2000.0107_RF54","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0140-6736(89)91608-5","article-title":"Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis","volume":"i","author":"Bachs","year":"1989","journal-title":"Lancet"},{"key":"10.1053\/bega.2000.0107_RF55","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/0016-5085(92)90335-V","article-title":"Effects of long-term rifampicin administration in primary biliary cirrhosis","volume":"102","author":"Bachs","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0107_RF56","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/0016-5085(90)90027-X","article-title":"Rifampin relieves pruritus in children with cholestatic liver disease","volume":"98","author":"Cynamon","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0107_RF57","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/0016-5085(88)90442-8","article-title":"Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial","volume":"94","author":"Ghent","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0107_RF58","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/adc.69.1.141","article-title":"Effect of rifampicin in the treatment of pruritus in hepatic cholestasis","volume":"69","author":"Gregorio","year":"1993","journal-title":"Archives of Disease in Childhood"},{"key":"10.1053\/bega.2000.0107_RF59","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/BF00544371","article-title":"Effect of rifampicin treatment on hepatic drug metabolism and serum bile acids in patients with primary biliary cirrhosis","volume":"28","author":"Hoensch","year":"1985","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1053\/bega.2000.0107_RF60","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/BF01300759","article-title":"Treatment of pruritus of primary biliary cirrhosis with rifampin","volume":"36","author":"Podesta","year":"1991","journal-title":"Digestive Disease Science"},{"key":"10.1053\/bega.2000.0107_RF61","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00004836-199004000-00012","article-title":"Failure of rifampin to relieve pruritus in chronic liver disease","volume":"12","author":"Woolf","year":"1990","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1053\/bega.2000.0107_RF62","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2125.1980.tb01742.x","article-title":"Naloxone modulates the perception of itch in man","volume":"10","author":"Summerfield","year":"1980","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1053\/bega.2000.0107_RF63","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0016-5085(93)90858-A","article-title":"Subhypnotic doses of propofol relieve pruritus associated with liver disease","volume":"104","author":"Borgeat","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0107_RF64","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1055\/s-2008-1040506","article-title":"Liver transplantation for primary biliary cirrhosis","volume":"9","author":"Tzakis","year":"1989","journal-title":"Seminars in Liver Disease"},{"key":"10.1053\/bega.2000.0107_RF65","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/0016-5085(88)90014-5","article-title":"Transplantation for primary biliary cirrhosis","volume":"94","author":"Esquivel","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0107_RF66","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1056\/NEJM198906293202602","article-title":"Efficacy of liver transplantation in patients with primary biliary cirrhosis","volume":"320","author":"Markus","year":"1989","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2000.0107_RF67","first-page":"47","article-title":"Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment","volume":"89","author":"Crippin","year":"1994","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2000.0107_RF68","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1440-1746.1991.tb00909.x","article-title":"Transplantation in primary biliary cirrhosis","volume":"6","author":"Sallie","year":"1991","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1053\/bega.2000.0107_RF69","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.1840180617","article-title":"Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation","volume":"18","author":"Balan","year":"1993","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0107_RF70","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0168-8278(05)80497-0","article-title":"Is there recurrence of primary biliary cirrhosis after liver transplantation? A clinicopathologic study in long-term survivors","volume":"20","author":"Gouw","year":"1994","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0107_RF71","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0016-5085(89)90643-4","article-title":"Evidence for disease recurrence after liver transplantation for primary biliary cirrhosis","volume":"97","author":"Polson","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0107_RF72","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0168-8278(05)80244-2","article-title":"Primary biliary cirrhosis. Histologic evidence of disease recurrence after liver transplantation","volume":"18","author":"Hubscher","year":"1993","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0107_RF73","doi-asserted-by":"crossref","first-page":"107S","DOI":"10.1002\/hep.1840040725","volume":"4","year":"1984","journal-title":"Hepatology"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691800901070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691800901070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T15:05:52Z","timestamp":1581001552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691800901070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":73,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,8]]}},"alternative-id":["S1521691800901070"],"URL":"https:\/\/doi.org\/10.1053\/bega.2000.0107","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2000,8]]}}}